Larissa Maria Cardoso Lima Rodrigues
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Previous Organizations / Institutes
The organizations / institutes from the scholar's other articles in the past ten years
Research Subjects
Larissa Maria Cardoso Lima Rodrigues has a total of 11 co-authors. Here are the top co-authors by number of shared publications:
- Ariel Oliveira Celestino
Universidade Federal de Sergipe
2 shared publications - Camila Mendonça França
Universidade Federal de Sergipe, Brasil
2 shared publications - Ikaro Daniel de Carvalho Barreto
Universidade Federal de Sergipe
2 shared publications - Isabel Ribeiro Santana Lopes
Universidade Federal de Sergipe, Brasil
2 shared publications - Pablo Amercio Silva Lima
Universidade Federal de Sergipe, Brazil
2 shared publications - Ricardo Queiroz Gurgel
Universidade Federal de Sergipe, Brasil
2 shared publications
Latest Publications
- Open Access
- 2 March 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (3)
Avaliação do perfil epidemiológico das pacientes com Doença Trofoblástica Gestacional atendidas no Centro de Referência de Sergipe
Objetivo: Descrever o perfil epidemiológico das pacientes com Doença Trofoblástica Gestacional (DTG) em Sergipe. Métodos: Trata-se de um estudo observacional, descritivo, colaborativo, realizado com pacientes do sexo feminino com diagnóstico de DTG através da aplicação de questionário. Foram avaliadas 86 mulheres com DTG atendidas no centro de referência em Sergipe, no Hospital Universitário da Universidade Federal de Sergipe (HU-UFS). Resultados: Após análise dos 86 questionários incluídos, foi observado que maioria das pacientes estudadas são mulheres com idade igual ou superior a 35 anos (57,1%), a cor parda foi a de maior prevalência (77,8%) e em grande parte católicas (52,7%). Quanto ao nível de escolaridade até o 2º grau completo foi o mais comum (37,2%) mais da metade já haviam apresentado uma gestação prévia (60,5%). Em sua grande maioria possuem uma parceria (92,5 %) renda mensal familiar de até 1 salário mínimo (73,6%) e residentes do interior do estado de Sergipe (70,0%). Conclusão: O perfil traçado foi de mulheres com idade igual ou superior a 35 anos, pardas, católicas, com escolaridade até o 2º grau completo, com história prévia de gestação, com parceria presente, com renda mensal até 1 salário mínimo e que veem do interior de Sergipe para receber tratamento no Centro de Referência do Estado para DTG.
- 2 March 2021
- Published by Research, Society and Development in Research, Society and Development
- Vol. 10 (3)
Open AccessAvaliação do perfil epidemiológico das pacientes com Doença Trofoblástica Gestacional atendidas no Centro de Referência de Sergipe
Objetivo: Descrever o perfil epidemiológico das pacientes com Doença Trofoblástica Gestacional (DTG) em Sergipe. Métodos: Trata-se de um estudo observacional, descritivo, colaborativo, realizado com pacientes do sexo feminino com diagnóstico de DTG através da aplicação de questionário. Foram avaliadas 86 mulheres com DTG atendidas no centro de referência em Sergipe, no Hospital Universitário da Universidade Federal de Sergipe (HU-UFS). Resultados: Após análise dos 86 questionários incluídos, foi observado que maioria das pacientes estudadas são mulheres com idade igual ou superior a 35 anos (57,1%), a cor parda foi a de maior prevalência (77,8%) e em grande parte católicas (52,7%). Quanto ao nível de escolaridade até o 2º grau completo foi o mais comum (37,2%) mais da metade já haviam apresentado uma gestação prévia (60,5%). Em sua grande maioria possuem uma parceria (92,5 %) renda mensal familiar de até 1 salário mínimo (73,6%) e residentes do interior do estado de Sergipe (70,0%). Conclusão: O perfil traçado foi de mulheres com idade igual ou superior a 35 anos, pardas, católicas, com escolaridade até o 2º grau completo, com história prévia de gestação, com parceria presente, com renda mensal até 1 salário mínimo e que veem do interior de Sergipe para receber tratamento no Centro de Referência do Estado para DTG.
- Open Access
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 54, e00332021
Prevalence of intestinal parasitic infections in Brazil: a systematic review
Parasitic infections are considered a major public health problem due to their associated morbimortality and negative impact on physical and intellectual development, especially in the at-risk pediatric group. Periodic prophylactic administration of antiparasitic agents against soil-transmitted helminths is recommended by the World Health Organization (WHO) to control parasitic infections and disease burden. We aimed to evaluate the prevalence of intestinal parasitic infections in Brazil. We performed a systematic review by searching the literature found in the PubMed, LILACS, and SciELO databases, followed by a meta-analysis of the proportions from studies published in English, Portuguese, and/or Spanish from January 2000 to May 2018. This systematic review was registered in the PROSPERO database (CRD42018096214). The prevalence of intestinal parasitic infections (protozoa and/or helminths) in Brazil was 46% (confidence interval: 39-54%), with 99% heterogeneity. Prevalence varied by region: 37%, 51%, 50%, 58%, and 41% in the Southeast, South, Northeast, North, and Central-West regions, respectively. Most studies (32/40) evaluated children (<18 years) and found an average prevalence of 51%. Children also had the highest prevalence in all four regions: Central-West (65%), South (65%), North (58%), Northeast (53%), and Southeast (37%). However, most studies evaluated specific populations, which may have created selection bias. Presumably, this review of intestinal parasitic diseases in Brazil includes the most studies and the largest population ever considered. The prevalence of intestinal parasitic infections is high in Brazil, and anthelmintic drugs should be administered periodically as a prophylactic measure, as recommended by the WHO.
- 1 January 2021
- Published by FapUNIFESP (SciELO) in Revista da Sociedade Brasileira de Medicina Tropical
- Vol. 54, e00332021
Open AccessPrevalence of intestinal parasitic infections in Brazil: a systematic review
Parasitic infections are considered a major public health problem due to their associated morbimortality and negative impact on physical and intellectual development, especially in the at-risk pediatric group. Periodic prophylactic administration of antiparasitic agents against soil-transmitted helminths is recommended by the World Health Organization (WHO) to control parasitic infections and disease burden. We aimed to evaluate the prevalence of intestinal parasitic infections in Brazil. We performed a systematic review by searching the literature found in the PubMed, LILACS, and SciELO databases, followed by a meta-analysis of the proportions from studies published in English, Portuguese, and/or Spanish from January 2000 to May 2018. This systematic review was registered in the PROSPERO database (CRD42018096214). The prevalence of intestinal parasitic infections (protozoa and/or helminths) in Brazil was 46% (confidence interval: 39-54%), with 99% heterogeneity. Prevalence varied by region: 37%, 51%, 50%, 58%, and 41% in the Southeast, South, Northeast, North, and Central-West regions, respectively. Most studies (32/40) evaluated children (<18 years) and found an average prevalence of 51%. Children also had the highest prevalence in all four regions: Central-West (65%), South (65%), North (58%), Northeast (53%), and Southeast (37%). However, most studies evaluated specific populations, which may have created selection bias. Presumably, this review of intestinal parasitic diseases in Brazil includes the most studies and the largest population ever considered. The prevalence of intestinal parasitic infections is high in Brazil, and anthelmintic drugs should be administered periodically as a prophylactic measure, as recommended by the WHO.
- Open Access
- 31 October 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (11)
Periodic deworming programme in Brazil
To evaluate the periodic deworming programme (PDP) against soil-transmitted helminth infection and estimate the cost-benefit of this action in a Northeastern Brazilian State. An observational descriptive study was peformed by two branches: an epidemiological analysis of parasitological stool tests positivity in the 7 health micro-regions of Sergipe State, from January to June 2019, and a cost-benefitial analysis through comparison between estimated costs of PDP and conventional diagnose and treatment method from 2014 to 2018. From the 1110 parasitological stool tests evaluated, 317 were positive: 20 (1.8 %) for helminths and 307 (26.7%) for protozoan parasites. Among positive tests, 61 (19.2%) were in PDP age target group (5-14 years). An annual average of 255,283 Albendazole tablets (400mg, single dose) were distributed with an annual average coverage rate of 84.2%. To support the programme, approximately R$ 281,859.25 (US$ 89,775.67) were transferred per year to the state of Sergipe. PDP estimated cost-effectiveness was R$ 1.10 (US$ 0.34) per event prevented and generated a cost-minimization of approximately R$ 335.617,60 (US$124,568.00) when compared to the conventional diagnose and treat method. The positive rates of soil-transmitted helminth infection in parasitological tests in Sergipe were low and the recommendation for PDP seems to be currently inadequate. Most positive tests were for commensal protozoa species. PDP estimated cost is lower than conventional diagnose and treatment method. Protozoa infections prevention policies should be evaluated as they are the major parasitic infection in our community after PDP.
- 31 October 2020
- Published by Research, Society and Development in Research, Society and Development
- Vol. 9 (11)
Open AccessPeriodic deworming programme in Brazil
To evaluate the periodic deworming programme (PDP) against soil-transmitted helminth infection and estimate the cost-benefit of this action in a Northeastern Brazilian State. An observational descriptive study was peformed by two branches: an epidemiological analysis of parasitological stool tests positivity in the 7 health micro-regions of Sergipe State, from January to June 2019, and a cost-benefitial analysis through comparison between estimated costs of PDP and conventional diagnose and treatment method from 2014 to 2018. From the 1110 parasitological stool tests evaluated, 317 were positive: 20 (1.8 %) for helminths and 307 (26.7%) for protozoan parasites. Among positive tests, 61 (19.2%) were in PDP age target group (5-14 years). An annual average of 255,283 Albendazole tablets (400mg, single dose) were distributed with an annual average coverage rate of 84.2%. To support the programme, approximately R$ 281,859.25 (US$ 89,775.67) were transferred per year to the state of Sergipe. PDP estimated cost-effectiveness was R$ 1.10 (US$ 0.34) per event prevented and generated a cost-minimization of approximately R$ 335.617,60 (US$124,568.00) when compared to the conventional diagnose and treat method. The positive rates of soil-transmitted helminth infection in parasitological tests in Sergipe were low and the recommendation for PDP seems to be currently inadequate. Most positive tests were for commensal protozoa species. PDP estimated cost is lower than conventional diagnose and treatment method. Protozoa infections prevention policies should be evaluated as they are the major parasitic infection in our community after PDP.